アフェレーシスのアジア太平洋市場2021-2028

◆英語タイトル:ASIA-PACIFIC APHERESIS MARKET FORECAST 2021-2028
◆商品コード:INK21JU037
◆発行会社(リサーチ会社):Inkwood Research
◆発行日:2021年5月3日
◆ページ数:168
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:アジア太平洋
◆販売価格オプション(消費税別)
Single UserUSD1,250 ⇒換算¥137,500見積依頼/購入/質問フォーム
Multi LicenseUSD1,500 ⇒換算¥165,000見積依頼/購入/質問フォーム
Enterprisewide PriceUSD2,000 ⇒換算¥220,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はInkwood Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Inkwood Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートはアフェレーシスのアジア太平洋市場について調査・分析し、調査範囲/手法、エグゼクティブサマリー、市場動向、主要分析、処置別分析、技術別分析、用途別分析、エンドユーザー別分析、地域別分析、競争状況などを掲載したものです。
【レポートの概要】

KEY FINDINGSThe Asia-Pacific apheresis market is anticipated to project a CAGR of 9.05% during the forecast period, 2021-2028. The increasing number of government initiatives, growing healthcare awareness, and blood donation camps are among the key growth enablers of the market.
MARKET INSIGHTS
Indonesia, Japan, China, Australia & New Zealand, India, South Korea, Thailand, Vietnam, and Rest of Asia-Pacific, are assessed for the growth analysis of the Asia-Pacific apheresis market. In Japan, the high awareness and initiatives to enhance the healthcare sector drive market growth. The company increasingly prioritizes innovations in the medical field. Apheresis is used to treat several diseases in the country. Low-density lipoprotein (LDL) apheresis has been developed to treat refractory familial hypercholesterolemia (FH). Further, almost 32% of Stage 3-5 chronic kidney disease patients are affected by anemia. This is because anemia is propelled by declining kidney function. The senior population is on the rise, adding to the burden of increasing chronic diseases. These require blood processing. Such factors enable the market growth of Japan.
In South Korea, the rising chronic disease burden and the development of new products drive market growth. The Korean Journal of Internal Medicine in 2017 stated that plasma exchange was used in patients with severe fever with SFTS (thrombocytopenia syndrome). The patients’ conditions improved as per the laboratory, clinical, and virological standards. Thus, plasma exchange is being evaluated as a therapeutic modality in rescue therapy for patients with rapidly progressing SFTS. Moreover, the Ministry of Health and Welfare launched policies to enhance management and supervision functions in blood transfusion services to tackle challenges related to an imbalance in blood supply and demand. Such factors fuel market growth in South Korea.
COMPETITIVE INSIGHTS
Some of the key players in the market include Terumo Corporation (Terumo BCT), Miltenyi Biotec, Medicap Clinic GmbH, Kawasumi Laboratories Inc, Medica SPA, Kaneka Corporation, etc.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

【レポートの目次】

TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
3. MARKET DYNAMICS
3.1. KEY DRIVERS
3.1.1. PREVAILING INCIDENCE OF HEMATOLOGIC DISEASES
3.1.2. ADVANCEMENT IN TECHNOLOGIES OF APHERESIS TECHNIQUE
3.1.3. GROWING GERIATRIC POPULATION
3.2. KEY RESTRAINTS
3.2.1. RISK OF BLOOD CONTAMINATION WHILE CONDUCTING TRANSFUSIONS
3.2.2. HIGH COST OF INVESTMENT ASSOCIATED WITH APHERESIS PROCEDURES
3.2.3. LACK OF SKILLED PROFESSIONALS IN DEVELOPING AND UNDERDEVELOPED COUNTRIES
4. KEY ANALYTICS
4.1. IMPACT OF COVID-19 ON APHERESIS MARKET
4.2. KEY MARKET TRENDS
4.3. PORTER’S FIVE FORCES ANALYSIS
4.3.1. BUYERS POWER
4.3.2. SUPPLIERS POWER
4.3.3. SUBSTITUTION
4.3.4. NEW ENTRY
4.3.5. INDUSTRY RIVALRY
4.4. OPPORTUNITY MATRIX
4.5. VENDOR LANDSCAPE
5. MARKET BY PROCEDURE
5.1. PLASMAPHERESIS
5.2. PLATELETPHERESIS
5.3. LEUKAPHERESIS
5.4. ERYTHROCYTAPHERESIS
5.5. OTHER APHERESIS PROCEDURES
6. MARKET BY TECHNOLOGY
6.1. CENTRIFUGATION
6.2. MEMBRANE SEPARATION
7. MARKET BY PRODUCT
7.1. DISPOSABLE APHERESIS KITS
7.2. APHERESIS MACHINE
8. MARKET BY APPLICATION
8.1. HEMATOLOGICAL DISORDERS
8.2. NEUROLOGICAL DISORDERS
8.3. AUTOIMMUNE DISORDERS
8.4. RENAL DISORDERS
8.5. OTHER APPLICATIONS
9. MARKET BY END-USER
9.1. BLOOD BANKS/ BLOOD DONATION CENTERS
9.2. HOSPITALS & CLINICS
9.3. AMBULATORY SURGICAL CENTERS
10. GEOGRAPHICAL ANALYSIS
10.1. ASIA-PACIFIC
10.1.1. MARKET SIZE & ESTIMATES
10.1.2. KEY GROWTH ENABLERS
10.1.3. KEY CHALLENGES
10.1.4. KEY PLAYERS
10.1.5. COUNTRY ANALYSIS
10.1.5.1. CHINA
10.1.5.2. JAPAN
10.1.5.3. INDIA
10.1.5.4. AUSTRALIA & NEW ZEALAND
10.1.5.5. SOUTH KOREA
10.1.5.6. INDONESIA
10.1.5.7. THAILAND
10.1.5.8. VIETNAM
10.1.5.9. REST OF ASIA-PACIFIC
11. COMPETITIVE LANDSCAPE
11.1. KEY STRATEGIC DEVELOPMENTS
11.1.1. MERGERS & ACQUISITIONS
11.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
11.1.3. PARTNERSHIPS & AGREEMENTS
11.1.4. BUSINESS EXPANSIONS, ANNOUNCEMENTS & DIVESTITURES
11.2. COMPANY PROFILES
11.2.1. ASAHI KASEI CORPORATION
11.2.2. BAXTER INTERNATIONAL INC
11.2.3. B BRAUN MELSUNGEN AG
11.2.4. CERUS CORPORATION
11.2.5. CYTOSORBENTS CORPORATION
11.2.6. FRESENIUS SE & CO KGAA (FRESENIUS KABI AG)
11.2.7. HAEMONETICS CORPORATION
11.2.8. HEMACARE CORPORATION
11.2.9. INFOMED
11.2.10. KANEKA CORPORATION
11.2.11. KAWASUMI LABORATORIES INC
11.2.12. MEDICAP CLINIC GMBH
11.2.13. MEDICA SPA
11.2.14. MILTENYI BIOTEC
11.2.15. TERUMO CORPORATION (TERUMO BCT)

LIST OF TABLES
TABLE 1: MARKET SNAPSHOT - APHERESIS
TABLE 2: ASIA-PACIFIC APHERESIS MARKET, BY PROCEDURE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 3: ASIA-PACIFIC APHERESIS MARKET, BY PROCEDURE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 4: ASIA-PACIFIC APHERESIS MARKET, BY TECHNOLOGY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 5: ASIA-PACIFIC APHERESIS MARKET, BY TECHNOLOGY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 6: ASIA-PACIFIC APHERESIS MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 7: ASIA-PACIFIC APHERESIS MARKET, BY PRODUCT, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 8: ASIA-PACIFIC APHERESIS MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 9: ASIA-PACIFIC APHERESIS MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 10: ASIA-PACIFIC APHERESIS MARKET, BY END-USER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 11: ASIA-PACIFIC APHERESIS MARKET, BY END-USER, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 12: ASIA-PACIFIC APHERESIS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 13: ASIA-PACIFIC APHERESIS MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 14: LEADING PLAYERS OPERATING IN ASIA-PACIFIC APHERESIS MARKET
TABLE 15: LIST OF MERGERS & ACQUISITIONS
TABLE 16: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 17: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 18: LIST OF BUSINESS EXPANSIONS, ANNOUNCEMENTS & DIVESTITURES


LIST OF FIGURES
FIGURE 1: KEY MARKET TRENDS
FIGURE 2: PORTER’S FIVE FORCES ANALYSIS
FIGURE 3: OPPORTUNITY MATRIX
FIGURE 4: VENDOR LANDSCAPE
FIGURE 5: ASIA-PACIFIC APHERESIS MARKET, BY PROCEDURE, IN 2020
FIGURE 6: ASIA-PACIFIC APHERESIS MARKET, BY PLASMAPHERESIS, 2021-2028 (IN $ MILLION)
FIGURE 7: ASIA-PACIFIC APHERESIS MARKET, BY PLATELETPHERESIS, 2021-2028 (IN $ MILLION)
FIGURE 8: ASIA-PACIFIC APHERESIS MARKET, BY LEUKAPHERESIS, 2021-2028 (IN $ MILLION)
FIGURE 9: ASIA-PACIFIC APHERESIS MARKET, BY ERYTHROCYTAPHERESIS, 2021-2028 (IN $ MILLION)
FIGURE 10: ASIA-PACIFIC APHERESIS MARKET, BY OTHER APHERESIS PROCEDURES, 2021-2028 (IN $ MILLION)
FIGURE 11: ASIA-PACIFIC APHERESIS MARKET, BY TECHNOLOGY, IN 2020
FIGURE 12: ASIA-PACIFIC APHERESIS MARKET, BY CENTRIFUGATION, 2021-2028 (IN $ MILLION)
FIGURE 13: ASIA-PACIFIC APHERESIS MARKET, BY MEMBRANE SEPARATION, 2021-2028 (IN $ MILLION)
FIGURE 14: ASIA-PACIFIC APHERESIS MARKET, BY PRODUCT, IN 2020
FIGURE 15: ASIA-PACIFIC APHERESIS MARKET, BY DISPOSABLE APHERESIS KITS, 2021-2028 (IN $ MILLION)
FIGURE 16: ASIA-PACIFIC APHERESIS MARKET, BY APHERESIS MACHINE, 2021-2028 (IN $ MILLION)
FIGURE 17: ASIA-PACIFIC APHERESIS MARKET, BY APPLICATION, IN 2020
FIGURE 18: ASIA-PACIFIC APHERESIS MARKET, BY HEMATOLOGICAL DISORDERS, 2021-2028 (IN $ MILLION)
FIGURE 19: PREVALENCE OF BLEEDING DISORDER IN ASIA-PACIFIC, 2019
FIGURE 20: ASIA-PACIFIC APHERESIS MARKET, BY NEUROLOGICAL DISORDERS, 2021-2028 (IN $ MILLION)
FIGURE 21: ASIA-PACIFIC APHERESIS MARKET, BY AUTOIMMUNE DISORDERS, 2021-2028 (IN $ MILLION)
FIGURE 22: ASIA-PACIFIC APHERESIS MARKET, BY RENAL DISORDERS, 2021-2028 (IN $ MILLION)
FIGURE 23: ASIA-PACIFIC APHERESIS MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)
FIGURE 24: ASIA-PACIFIC APHERESIS MARKET, BY END-USER, IN 2020
FIGURE 25: ASIA-PACIFIC APHERESIS MARKET, BY BLOOD BANKS/ BLOOD DONATION CENTERS, 2021-2028 (IN $ MILLION)
FIGURE 26: ASIA-PACIFIC APHERESIS MARKET, BY HOSPITALS & CLINICS, 2021-2028 (IN $ MILLION)
FIGURE 27: ASIA-PACIFIC APHERESIS MARKET, BY AMBULATORY SURGICAL CENTERS, 2021-2028 (IN $ MILLION)
FIGURE 28: ASIA-PACIFIC APHERESIS MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)
FIGURE 29: CHINA APHERESIS MARKET, 2021-2028 (IN $ MILLION)
FIGURE 30: JAPAN APHERESIS MARKET, 2021-2028 (IN $ MILLION)
FIGURE 31: INDIA APHERESIS MARKET, 2021-2028 (IN $ MILLION)
FIGURE 32: AUSTRALIA & NEW ZEALAND APHERESIS MARKET, 2021-2028 (IN $ MILLION)
FIGURE 33: SOUTH KOREA APHERESIS MARKET, 2021-2028 (IN $ MILLION)
FIGURE 34: INDONESIA APHERESIS MARKET, 2021-2028 (IN $ MILLION)
FIGURE 35: THAILAND APHERESIS MARKET, 2021-2028 (IN $ MILLION)
FIGURE 36: VIETNAM APHERESIS MARKET, 2021-2028 (IN $ MILLION)
FIGURE 37: REST OF ASIA-PACIFIC APHERESIS MARKET, 2021-2028 (IN $ MILLION)


【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[アフェレーシスのアジア太平洋市場2021-2028]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆